DARCY WIKOFF: Open Payments
NPI 1356898688 · CITRUS HEIGHTS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 15 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $223 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Dexcom, Inc. | 2 | $52 |
| PFIZER INC. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Cranial Technologies, Inc | 1 | $18 |
Products named: CAPLYTA, Dexcom G6 Transmitter, VRAYLAR, ZENPEP, SHINGRIX, Auvelity, PREVNAR 20, UBRELVY.
Industry payments across CA — which companies pay providers there.
